ProQR Therapeutics

ProQR Therapeutics is a Dutch biotechnology company focused on the development of therapeutics for genetic diseases. Our primary focus is on the development of a therapy for Cystic Fibrosis, an orphan disease that affects 70.000 patients worldwide and has a very large unmet medical need. Based on our proprietary platform technology we are developing a novel approach to treat the underlying cause of the disease.